Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat

Cell Biochemistry and Function

Volumn 24, Issue 4, 2006, Pages 357-361

  Iraz, Mustafa ^a   Ozerol, Elif ^a   Gulec, Mukaddes ^a   Tasdemir, Seda ^a   Idiz, Nuri ^b   Fadillioglu, Ersin ^a   Naziroglu, Mustafa ^c   Akyol, Omer ^d  

^a INONU UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Caffeic acid phenethyl ester; Cisplatin; Liver; Rat

Indexed keywords

ADENOSINE DEAMINASE; CAFFEIC ACID PHENETHYL ESTER; CATALASE; CISPLATIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; LIVER INJURY; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ADENOSINE DEAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS; CAFFEIC ACIDS; CATALASE; CISPLATIN; FEMALE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; LIVER; LIVER EXTRACTS; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 33746025372     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1232     Document Type: Article

References (27)

1. Fadillioglu E, Erdogan H, Sogut S, Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol 2003; 23: 71-74.
2. Fadillioglu E, Erdogan H. Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 2003; 47: 317-322.
3. Rosenberg B. Fundamental studies with cisplatin. Cancer 1985; 55: 2303-2315.
4. Mollman JE, Glover DJ, Hogan WM, Furman RE. Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721. Cancer 1988; 61: 2192-2195.
5. Screnci D, McKeage MJ. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J Inorg Biochem 1999; 77: 105-110.
6. Cersimo RJ. Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharm 1993; 27: 438-441.
7. Cavalli F, Tschopp L, Sonntag RW, Zimmermann A. A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment. Cancer Treat Rep 1978; 62: 2125-2126.
8. Pollera CF, Ameglio F, Nardi M, Vitelli G, Marolla P. Cisplatin-induced hepatic toxicity. J Clin Oncol 1987; 5: 318-319.
9. Naziroglu M, Karaoglu A, Aksoy OA. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004; 195: 221-230.
10. Akyol O, Herken H, Uz E, et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 995-1005.
11. Hepsen IF, Er H, Cekic O. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthal Res 1999; 31: 426-431.
12. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralik H, Akyol O. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg 1999; 16: 458-463.
13. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993; 329: 21-24.
14. Fadillioglu E, Oztas E, Erdogan H, et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 2004; 24: 47-52.
15. National Institutes of Health, USA. Guide for the Care and Use of Laboratory Animals. DHEW Publication No. 85-23, NIH, 1985.
16. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In Methods in Enzymology, Oxygen Radicals in Biological Systems, Vol. 186, Packer L, Glazer AN (eds). Academic Press: San Diego, CA, 1990; 407-421.
17. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
18. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
19. Prajda N, Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 1975; 59: 245-249.
20. Aebi H. Catalase. In Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: New York, 1974; 673-677.
21. Giusti G. Adenosine deaminase. In Methods of Enzymatic Analysis (2nd edn), Bergmeyer MV (ed.). Academic Press: New York, 1974; 1092-1098.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
23. Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993; 14: 1195-1201.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
25. Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998; 9: 1331-1337.
26. Zhou S, Palmeira CM, Wallace KB. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett 2001; 121: 151-157.
27. Arnhold J, Osipov AN, Spalteholz H, Panasenko OM, Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 2001; 31: 1111-1119.